a major indicator of insulin resistance, may exert its influence on the risk of coronary artery disease partially through disturbances of the hemostatic system. The relations of fasting insulin concentrations with the degree of coronary atherosclerosis, other coronary risk factors (including some markers of the insulin resistance syndrome such as body mass index and triglyceride), markers of inflammation, and hemostatic factors were investigated in 1484 patients with angina pectoris. Mean insulin levels were higher in patients with one or more coronary vessel stenoses than in those without (9.9 fiU/mL compared with 9.0 fiV/mh, P<.0001). However, the association with the presence of vessel stenoses was stronger in patients with a previous myocardial infarction than in those without. Insulin increased markedly (P<.0001) and independently of other risk factors with age, body mass index, triglyceride concentration, and markers of inflammation, such as white blood cell count and C-reactive protein. The strongest relations between insulin and hemostatic factors were observed with fibrinolytic variables, particularly plasminogen activator inhibitor-1 (PA1-1) levels (r=.44, P<.0001). This relation decreased somewhat (r=.29) after simultaneous adjustment for markers of the insulin resistance syndrome, mainly body mass index and triglycerides, but not after adjustment for markers of inflammation. Therefore, we propose that increased PAI-1 levels, which are essentially related to the classic metabolic aspect of the insulin resistance syndrome, have to be included in this syndrome. Insulin concentrations were also significantly related to a lesser extent with hemostatic variables that are considered as acute-phase markers, such as fibrinogen, von Willebrand factor, and factor VIII: c; these correlations were independent of joint associations with other coronary risk factors, including body mass index and triglyceride. Simultaneous adjustments for markers of inflammation substantially reduced the fibrinogen relation to insulin but only slightly modified those between insulin and von Willebrand factor and factor VIII :c. These results indicate that the insulin-fibrinogen relation is more related to the accompanying acute-phase reaction, whereas the link between insulin and von Willebrand factor and factor VIII: c may be due to nonspecific endothelial cell damage. (Arterioscler Thromb. 1993; 13:1865-1873 KEY WORDS • hemostatic system • plasminogen activator inhibitor-1 • fibrinogen • von Willebrand factor • factor VIII • insulin resistance • insulin • arteriosclerosis • angina pectoris • risk factors A therosclerosis appears to be caused by a number / \ of interacting factors, including disturbed lipid A. \ . metabolism, endothelial cell damage, hemostatic changes, monocyte invasion, and smooth muscle cell proliferation. Many clinical studies have also shown increased fasting insulin levels or insulin response to a glucose challenge in patients with ischemia of the heart, lower limbs, or brain (for a review, see Reference 1), and hyperinsulinemia has been considered a risk factor for myocardial infarction (MI) according to three pro-
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Methods
The design of the ECAT Angina Pectoris Study has been described in more detail elsewhere 21 ; only essential details are given here. Male and female patients of any age who underwent coronary angiography because of suspected coronary artery disease were recruited into the study from 18 European centers. The principal exclusions were patients who had suffered an acute MI within the preceding 2 months. A blood sample for the measurement of insulin and hemostatic tests was taken before the qualifying angiogram. It was requested that blood samples be taken before 10 AM and that patients should have fasted overnight and not have smoked for 24 hours. However, in eight centers it was not possible to follow the recommendation of fasting, and a light meal was allowed. In addition, for technical reasons, samples for insulin measurement were not available from two centers. In this report, therefore, we include the patients from only eight centers who were truly fasting and for whom insulin measurements were available.
For each patient at recruitment, baseline data were collected, comprising medical history, drug use at the time of blood sampling for insulin and hemostatic tests, smoking habits, a physical examination, and standard laboratory tests (including total cholesterol and triglycerides). The recorded drugs included )3-blockers, calcium antagonists, nitrates, diuretics, digitalis, antiplatelet drugs, heparin, and oral anticoagulants. The coronary angiography 21 included views of the left main, left anterior descending, circumflex, and right coronary vessels and measurement of left ventricular end-diastolic pressure (LVEDP) and ejection fraction. The angiographic results, recorded locally by a visual system at each center, classified the degree of stenosis in each vessel as <50% diameter stenosis, >50% stenosis, or total occlusion. For the purpose of this article, the angiographic results are expressed as the number of vessels (0 to 4) with >50% diameter stenosis or occlusion.
Assays
The conditions of blood sampling, storage, and execution of the hemostatic tests have been described separately in detail. 22 The majority of the hemostatic tests were performed locally at each center with centrally distributed reagents, and an external quality assessment scheme was used to monitor performance throughout the study. 23 Activated partial thromboplastin time (aPTT) and fibrinogen assays were performed on fresh plasma. For all other assays, plasma was prepared in <1 hour after blood sampling and snapfrozen at -80°C until use. A few tests (listed in the "Appendix") were performed at the central laboratory on frozen plasma transported on dry ice. 2123 The hemostatic assays performed were as follows. The platelet assays were /3-thromboglobulin and platelet factor 4. The coagulation assays were aPTT, fibrinogen, fibrinopeptide A, factor VII activity, von Willebrand factor-related antigen (vWF:Rag), factor VIII activity (VIII :c), antithrombin HI antigen and activity, and protein C antigen and activity. The fibrinolysis tests were plasminogen, a2-an tipla smm ) histidine-rich glycoprotein, PAI-1 antigen, PAI activity, tissue-type plasminogen activator antigen and activity before (TPA1) and after (TPA2) 10 minutes of venous occlusion, and euglobulin clot lysis time also before (ECLTl) and after (ECLT2) venous occlusion.
Insulin concentrations were measured at a central laboratory with a commercially available radioimmunoassay kit (CEA Sorin, Saluggia, Italy) on plasma samples that had been snap-frozen locally and transported to the responsible laboratory (Pr P. Vague, Marseille, France).
Results for hematocrit, white blood cell count (WBCC), whole-blood platelet count, and C-reactive protein (CRP) are also presented. CRP concentrations were measured at the central laboratory with a nephelometric method (the lowest detection limit of the assay was 0.7 mg/L; 27% of values were undetectable and for the statistical analysis were considered as 0.7 mg/L).
Statistical Analysis
Patients receiving insulin treatment were omitted from all analyses. A logarithmic transformation of insulin concentration was used in the statistical analysis to make its distribution more symmetrical; therefore, geometric mean insulin values are presented.
The relations between insulin and coronary disease risk factors were investigated by using multiple regression as follows. After adjusting for any systematic differences between centers, the relations with age, sex, and current drug use were investigated. After adjusting for these variables, associations with each of the following variables were then considered: the number of vessels with angiographically determined stenoses, history of MI, diabetes and elevated BP considered simultaneously, chest pain (considered as a gradient: crescendo, resting, effort, and no angina), ejection fraction and LVEDP considered simultaneously, smoking habit, systolic BP, body mass index (BMI; weight/height 2 ), and total cholesterol and triglycerides considered simultaneously. The probability values presented in Table 2 are derived from these multiple regressions.
For the hemostatic variables, adjustments were first made to them for any significant (P<.01) effects of center, age, sex, drug use, and ABO blood group and second, for the coronary risk factors listed above. Correlations with logarithmic insulin concentration are thus presented with and without adjustment for these coronary risk factors. For ECLT, observation was limited to 300 minutes for practical reasons, and in the statistical analysis the proportion of ECLT values >300 minutes was analyzed by discriminant analysis. Similarly, the statistical analysis of TPA activity was based on the proportion of nonzero values. Values of protein C, factor VII, and aPTT were considered unknown for patients currently taking oral anticoagulants.
Results
Insulin concentrations increased with age in these angina patients (Table 1 , P<.0001), the trends being similar in men and women. This age increase was still clear (/ > =.0002) after adjustment for all of the other coronary risk factors. Most of the drugs being used at the time of blood sampling had no apparent effect on insulin concentrations. However, the use of both diuretics and digitalis was associated with increased insulin levels. The mean insulin concentrations in diuretic users (n=255) were 11.3 versus 9.3 /xU/mL in nonusers (P<.0001) and for digitalis users (n=183), 11.1 versus 9.5 AtU/mL in nonusers (P=.0002); these associations diminished only slightly after adjustment for the coronary risk factors. The use of j8-blockers was not significantly associated with insulin concentrations.
Insulin concentrations were, on average (after adjustment for center and age), slightly higher in the 46% of patients with a previous MI (9.9 versus 9.5 £<,U/mL, P=.O4); none of these acute events had occurred in the previous 2 months (an exclusion criterion of the study), but about half had occurred 3 to 6 months before recruitment. Insulin levels were substantially higher in the 33% of patients with a history of elevated BP (untreated diastolic BP >95 mm Hg) (10.3 versus 9.4 /nU/mL, P=.0009) and in the 10% with non-insulintreated diabetes (11.0 versus 9.5 /iU/mL, /><.OOO1).
Those patients who had a greater number of coronary vessels with >50% stenoses tended to have higher insulin concentrations ( Table 2 ). The principal difference occurred between those with no stenoses >50% and those with any stenoses (Z'<.0001); indeed, for those patients with one or more such stenoses, the trend of insulin concentration was not significant (P>.2). However, the difference between those without and those with any such stenoses remained apparent (/ > =.O4) even after adjusting for all other coronary risk factors. Insulin concentrations according to both the history of MI and the extent of vessel disease are shown in Table 3 . Insulin levels were more clearly associated with the extent of vessel disease in patients with a history of MI, whereas little association was observed in patients without a previous MI. No difference in the use of /3-blockers could explain these relations. Also, no effect of the recentness of MI was observed.
As expected, insulin increased markedly with both BMI and triglyceride concentrations ( Table 2) . Only a small part of the relation with BMI was apparently mediated by triglycerides or vice versa. However, the relation of insulin with cholesterol concentration became nonsignificant after adjusting for triglycerides (Table 2) . Similarly, the association with systolic BP (Table 2 ) appeared substantially secondary to the relation of insulin with BMI. The slightly higher average insulin levels in reported exsmokers and the small trend with the severity of angina symptoms (Table 2) 
2).
The relations between insulin and hemostatic test results are shown in Table 4 . For those hemostatic variables that showed a significant (P<.01) relation, mean hemostatic test results according to approximate quintile groups of insulin concentration are presented, together with the overall correlation with logarithmic insulin concentrations. Hemostatic tests that were measured but that do not appear in Table 4 were not significantly associated with insulin. (TPA activity before venous occlusion is an exception and is presented for comparison with other TPA measures.)
Among the coagulation variables, higher insulin concentrations were related to increased fibrinogen, vWF: Rag, VIII: c, and protein C. In the case of protein C, the correlations seemed to be substantially dependent on joint associations with coronary risk factors (notably triglycerides) and were reduced after adjusting for them (Table 4) .
The strongest relations of insulin with hemostatic assays were with fibrinolytic variables, particularly with PAI-1 levels, which were substantially higher in patients with higher insulin concentrations. A higher insulin level was also associated with raised TPA antigen levels (mainly before venous occlusion) and to a lesser extent with raised plasminogen levels. A higher insulin level was also accompanied by prolonged ECLTs (both before and after venous occlusion) and decreased TPA activity after venous occlusion. These correlations were somewhat reduced but not eliminated by adjusting for the effects of other risk factors, notably BMI and triglycerides.
Insulin concentrations were also associated for WBCC and CRP, the correlations being almost unchanged after adjustment for other risk factors. To evaluate whether the relation of hemostatic factors with insulin might be somewhat a reflection of a general acute-phase inflammatory reaction, adjustments were also made separately for CRP and WBCC. The results (Table 5 ) indicated that such adjustments substantially reduced the fibrinogen relation to insulin and slightly modified the relation between insulin and vWF: Rag or VIII: c, whereas adjusting for CRP and WBCC did not modify the relation between insulin and PAI-1 or TPA antigen.
Discussion
This study is the first that includes measurements of fasting insulin, hemostatic variables, lipid components, acute-phase markers, and an evaluation of the extent of coronary artery disease in such a large sample of patients with angina pectoris. It has been shown in prospective studies that high insulin values are predictive of MI, ie, the thrombotic event. 24 Insulin has been considered to be an atherogenic hormone in experimental animals and humans, 12428 but until now, the possible link between high insulin levels and the extent or Insulin concentrations are in microunits per milliliter and are adjusted for center and age.
•Probability value for trend derived from multiple regression, adjusting for center, age, and use of diuretics and digitalis. For smoking, probability value is for any differences between the four categories. tProbability value for cholesterol from multiple regression adjusting also for logarithmically transformed triglycerides and vice versa. 29 did not find a relation between hyperinsulinemia and coronary atheromatous score. However, in a prospective study, the same group 30 showed that among survivors of MI with glucose intolerance, PAI-1 levels and insulin release correlated with the progression of coronary atherosclerosis as evaluated by a comparison of the angiograms performed 3 to 6 months and 5 years after MI; in contrast, they found that low-density lipoprotein cholesterol was the best predictor in patients with normal glucose tolerance. For patients undergoing coronary angiography, one crosssectional study of 120 patients 31 did not show any link between fasting insulin levels and the number of vessels with atherosclerotic lesions, whereas another 8 demonstrated among 67 patients a significant correlation between insulin values and a severity score that included the number and extent of coronary stenoses.
The present study gives data for about 1500 patients and shows that mean insulin values are higher in patients with one or more stenoses >50% compared with those without coronary stenoses. Interestingly, insulin levels were apparently associated with the extent of the vessel disease only in patients with a previous MI ( Table 3 ). The same analysis was made for variables other than insulin: BMI, triglyceride, cholesterol, ejection fraction, LVEDP, PAI-1 antigen, PAI activity, fibrinogen, CRP, and WBCC. Only cholesterol and ejection fraction showed strong evidence of a different association with vessel disease according to whether the patients had or did not have a past history of MI. The difference for cholesterol according to vessel disease was more evident in patients without a past history of MI, and ejection fraction was markedly lower in patients with both vessel disease and a past history of MI (Table  3 ). The progression of coronary disease could be dependent on different mechanisms according to whether a previous MI has occurred or not. In patients with a previous MI, who have a greater thrombotic tendency, the extent of vessel disease was related to the degree of hyperinsulinemia. In patients without a previous coronary thrombosis, the extent of the vessel wall disease was apparently independent of hyperinsulinemia and could be more dependent on other mechanisms such as a higher serum cholesterol value.
The present study of angina patients has confirmed the well-known link between hyperinsulinemia and the other components of the insulin resistance syndrome, 67 fasting insulin in fact being considered the hallmark of this syndrome: Insulin levels increased in parallel with systolic BP, BMI, and triglycerides, whereas as expected, no link was observed with cholesterol after adjustment for triglycerides. Insulin levels also increased with age. These multiple interrelations have to be taken into account when interpreting the relation between hemostatic factors, mainly PAI-1, and other risk factors.
Insulin was associated with markers of inflammation such as WBCC and CRP, and hemostatic variables that are considered to be acute-phase markers: fibrinogen, vWF, VIII :c, and plasminogen. These markers, which could be included in the "hematological stress syndrome" previously described in atherosclerotic patients, 32 could derive from a nonspecific, acute-phase reaction following tissue damage and atherosclerosis. The correlation between insulin and all of these biological markers was not substantially modified after adjustment for other coronary risk factors, such as BMI or triglycerides, except for plasminogen.
The analysis of mean fibrinolytic assay results according to insulin values (Table 4) gives some important information. The very strong association between PAI-1 levels and insulin values, already described in several clinical conditions, 14 was again demonstrated. Similar correlation coefficients were observed between insulin and PAI activity or PAI-1 antigen. The association of insulin with the other fibrinolytic assays is related to the 'Statistical analysis on logarithmically transformed data, so geometric means are presented. tOmitting patients on oral anticoagulants. Correlation with logarithmic insulin concentrations, adjusting only for center, age, sex, use of drugs, and ABO blood group. {(Correlation after adjusting, in addition, for other coronary heart disease risk factors.
effect of PAI-1 levels on these assays. A detailed discussion has been given in previous studies.
'
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- 34 The correlation coefficients between insulin and PAI-1 and other fibrinolytic variables decreased after simultaneous adjustment for other coronary risk factors (BP, BMI, triglycerides, cholesterol, and smoking). However, smoking was only very weakly related to insulin, so adjustment for smoking had very little effect. The relation of BP with insulin was apparently secondary to that of BMI with insulin. Thus, adjustment for BP also had little effect. Similarly, the association of cholesterol with insulin is apparently secondary to that between triglycerides and insulin. The adjustment in Table 4 for "other coronary risk factors" is therefore principally an adjustment for BMI and triglycerides. PAI-1 and the other fibrinolytic factors were very strongly related to both BMI and triglycerides. 21 Thus, adjustment had a marked effect. The mechanisms linking hyperinsulinemia to increased PAI-1 levels are still unclear. It has been suggested that insulin may act directly or indirectly via lipoprotein changes in the cells that synthesize PAI-l. 14 -3541 It has been shown that PAI-1 synthesis by both endothelial cells and hepatocytes in culture can be affected by high insulin concentrations and lipoprotein abnormalities. 35 " 41 It has also been proposed that hepatocytes in culture present an insulin resistance state that mimics the in vivo situations and respond in an abnormal way to stimulating agents like insulin. 42 The relation between insulin levels and fibrinogen has been previously described by several authors.
8 " 1 ' Again, the mechanism of this relation is poorly understood. To explain this relation, the role of free fatty acid release in insulin resistance could be proposed, since this process is accompanied by a rise in plasma fibrinogen levels in a wide variety of experimental and clinical situations. 43 Moreover, it has been shown in vitro that saturated free fatty acid stimulates fibrinogen synthesis by mouse liver sections. 44 The insulin-fibrinogen relation could be due to the presence of an inflammatory reaction accompanying atherosclerosis as previously mentioned, with a direct effect of cytokines on hepatic synthesis. The results of this study favor this last hypothesis, the evidence for a relation between insulin and fibrinogen, independent of the inflammatory reaction, being weak. The relations between insulin levels and vWF or factor VIII :c are somewhat difficult to interpret, as no links with metabolic disorders such as BMI or triglyceride and a weak link with acute-phase markers are shown. These results could be attributed to nonspecific endothelial cell damage. No link between insulin and platelet factors such as j3-thromboglobulin or platelet factor-4 was found. This may be due to technical problems with uninterpretable high values due to in vitro platelet release.
In conclusion, increased concentrations of hemostatic variables, principally PAI-1, accompany hyperinsulinemia, hypertriglyceridemia, hypertension, and obesity, all of which are included in the syndrome of insulin resistance. This syndrome is associated with the development of coronary artery disease.
Increases in the concentration of fibrinogen have been shown to be a risk factor for the development of coronary disease and of PAI activity for recurrent infarction in young male survivors of MI. 1520 Such factors may play a role by increasing fibrin deposition and thereby promoting the development of atherothrombosis. 45 Future studies aimed in improving the degree of insulin resistance may show a favorable effect on the coagulation and fibrinolytic system. Such an effect could slow the development of coronary artery disease.
